Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism APAF1 inhibitors(Apoptotic protease-activating factor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization Loop Therapeutics, Inc.Startup |
Active Organization Loop Therapeutics, Inc.StartupSpiral Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC31H32Cl2N4O4S |
InChIKeyXLXXBYJYWULGGD-UHFFFAOYSA-N |
CAS Registry1263477-83-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hearing Loss | Phase 1 | - | Loop Therapeutics, Inc.Startup | - |
Hearing Loss | Phase 1 | - | Spiral Therapeutics, Inc.Startup | - |
Deafness | Preclinical | AU | Spiral Therapeutics, Inc.Startup | 18 Dec 2018 |